Adoption of Broad Genomic Profiling in Patients With Cancer
This cross-sectional study examines the use of broad genomic profiling in patients with metastatic cancer.
Authors
- John Rothen
- Carolyn Jean Presley (ORCID: https://orcid.org/0000-0002-2607-5639)
- Sarah B. Goldberg (ORCID: https://orcid.org/0000-0002-0920-1381)
- Ronac Mamtani (ORCID: https://orcid.org/0000-0002-8267-5356)
- Natalia Kunst (ORCID: https://orcid.org/0000-0002-2409-4246)
- Shuangge Ma (ORCID: https://orcid.org/0000-0001-9001-4999)
- Cary P. Gross (ORCID: https://orcid.org/0000-0002-4974-935X)
- Michaela A. Dinan (ORCID: https://orcid.org/0000-0003-4849-4743)
- Wang Xiao (ORCID: https://orcid.org/0009-0007-1589-6830)
- Pamela R. Soulos
- Shi-Yi Wang
- Sida Huang
- Jessica B. Long
Institutions
- Yale Cancer Center (US)
- Yale University (US)
- University of York (GB)
- The Ohio State University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1001/jamaoncol.2025.0499
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94